Asia-Pacific Active Pharmaceutical Ingredient Market Report 2017
- QYR1963679
- 125 Pages
- October 2017
- Pharmaceuticals
Geographically, this report split Asia-Pacific into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Active Pharmaceutical Ingredient for these regions, from 2012 to 2022 (forecast), including
China
Japan
South Korea
Taiwan
India
Southeast Asia
Australia
Asia-Pacific Active Pharmaceutical Ingredient market competition by top manufacturers/players, with Active Pharmaceutical Ingredient sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Teva
Novartis
Pfizer
Johnson & Johnson
Mylan
North China Pharmaceutical Group
Dr. Reddy’s Laboratories
Roche
Aurobindo pharma
Sun Pharmaceutical Industries
Boehringer Ingelheim GmbH
Bayer
BASF
DSM
Zhejiang Medicine
Biocon
Johnson Matthey
Hisun Pharmacy
Cambrex
Shandong Xinhua Pharmaceutical
Lonza group
Huahai Pharmaceutical
Haerbin Pharmaceutical Group
Cipla
Tian Yao
Lupin
North East Pharmaceutical
Albemarle
Shandong Lukang Pharmaceutical
Jiangsu?Hengrui Medicine
On the basis of product, this report displays the sales volume (K MT), revenue (Million USD), product price (USD/MT), market share and growth rate of each type, primarily split into
Synthetic API
Biotech API
Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K MT), market share and growth rate of Active Pharmaceutical Ingredient for each application, includin
Chemical
Deodorant
Dailylife
If you have any special requirements, please let us know and we will offer you the report as you want.
Asia-Pacific Active Pharmaceutical Ingredient Market Report 2017
1 Active Pharmaceutical Ingredient Overview
1.1 Product Overview and Scope of Active Pharmaceutical Ingredient
1.2 Classification of Active Pharmaceutical Ingredient by Product Category
1.2.1 Asia-Pacific Active Pharmaceutical Ingredient Market Size (Sales) Comparison by Types (2012-2022)
1.2.2 Asia-Pacific Active Pharmaceutical Ingredient Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Synthetic API
1.2.4 Biotech API
1.2.5 Other
1.3 Asia-Pacific Active Pharmaceutical Ingredient Market by Application/End Users
1.3.1 Asia-Pacific Active Pharmaceutical Ingredient Sales (Volume) and Market Share Comparison by Applications (2012-2022)
1.3.2 Chemical
1.3.3 Deodorant
1.3.4 Dailylife
1.4 Asia-Pacific Active Pharmaceutical Ingredient Market by Region
1.4.1 Asia-Pacific Active Pharmaceutical Ingredient Market Size (Value) Comparison by Region (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Japan Status and Prospect (2012-2022)
1.4.4 South Korea Status and Prospect (2012-2022)
1.4.5 Taiwan Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.4.7 Southeast Asia Status and Prospect (2012-2022)
1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Active Pharmaceutical Ingredient (2012-2022)
1.5.1 Asia-Pacific Active Pharmaceutical Ingredient Sales and Growth Rate (2012-2022)
1.5.2 Asia-Pacific Active Pharmaceutical Ingredient Revenue and Growth Rate (2012-2022)
2 Asia-Pacific Active Pharmaceutical Ingredient Competition by Players/Suppliers, Region, Type and Application
2.1 Asia-Pacific Active Pharmaceutical Ingredient Market Competition by Players/Suppliers
2.1.1 Asia-Pacific Active Pharmaceutical Ingredient Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Asia-Pacific Active Pharmaceutical Ingredient Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Active Pharmaceutical Ingredient (Volume and Value) by Type
2.2.1 Asia-Pacific Active Pharmaceutical Ingredient Sales and Market Share by Type (2012-2017)
2.2.2 Asia-Pacific Active Pharmaceutical Ingredient Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Active Pharmaceutical Ingredient (Volume) by Application
2.4 Asia-Pacific Active Pharmaceutical Ingredient (Volume and Value) by Region
2.4.1 Asia-Pacific Active Pharmaceutical Ingredient Sales and Market Share by Region (2012-2017)
2.4.2 Asia-Pacific Active Pharmaceutical Ingredient Revenue and Market Share by Region (2012-2017)
3 China Active Pharmaceutical Ingredient (Volume, Value and Sales Price)
3.1 China Active Pharmaceutical Ingredient Sales and Value (2012-2017)
3.1.1 China Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2012-2017)
3.1.2 China Active Pharmaceutical Ingredient Revenue and Growth Rate (2012-2017)
3.1.3 China Active Pharmaceutical Ingredient Sales Price Trend (2012-2017)
3.2 China Active Pharmaceutical Ingredient Sales Volume and Market Share by Type
3.3 China Active Pharmaceutical Ingredient Sales Volume and Market Share by Application
4 Japan Active Pharmaceutical Ingredient (Volume, Value and Sales Price)
4.1 Japan Active Pharmaceutical Ingredient Sales and Value (2012-2017)
4.1.1 Japan Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2012-2017)
4.1.2 Japan Active Pharmaceutical Ingredient Revenue and Growth Rate (2012-2017)
4.1.3 Japan Active Pharmaceutical Ingredient Sales Price Trend (2012-2017)
4.2 Japan Active Pharmaceutical Ingredient Sales Volume and Market Share by Type
4.3 Japan Active Pharmaceutical Ingredient Sales Volume and Market Share by Application
5 South Korea Active Pharmaceutical Ingredient (Volume, Value and Sales Price)
5.1 South Korea Active Pharmaceutical Ingredient Sales and Value (2012-2017)
5.1.1 South Korea Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2012-2017)
5.1.2 South Korea Active Pharmaceutical Ingredient Revenue and Growth Rate (2012-2017)
5.1.3 South Korea Active Pharmaceutical Ingredient Sales Price Trend (2012-2017)
5.2 South Korea Active Pharmaceutical Ingredient Sales Volume and Market Share by Type
5.3 South Korea Active Pharmaceutical Ingredient Sales Volume and Market Share by Application
6 Taiwan Active Pharmaceutical Ingredient (Volume, Value and Sales Price)
6.1 Taiwan Active Pharmaceutical Ingredient Sales and Value (2012-2017)
6.1.1 Taiwan Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2012-2017)
6.1.2 Taiwan Active Pharmaceutical Ingredient Revenue and Growth Rate (2012-2017)
6.1.3 Taiwan Active Pharmaceutical Ingredient Sales Price Trend (2012-2017)
6.2 Taiwan Active Pharmaceutical Ingredient Sales Volume and Market Share by Type
6.3 Taiwan Active Pharmaceutical Ingredient Sales Volume and Market Share by Application
7 India Active Pharmaceutical Ingredient (Volume, Value and Sales Price)
7.1 India Active Pharmaceutical Ingredient Sales and Value (2012-2017)
7.1.1 India Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2012-2017)
7.1.2 India Active Pharmaceutical Ingredient Revenue and Growth Rate (2012-2017)
7.1.3 India Active Pharmaceutical Ingredient Sales Price Trend (2012-2017)
7.2 India Active Pharmaceutical Ingredient Sales Volume and Market Share by Type
7.3 India Active Pharmaceutical Ingredient Sales Volume and Market Share by Application
8 Southeast Asia Active Pharmaceutical Ingredient (Volume, Value and Sales Price)
8.1 Southeast Asia Active Pharmaceutical Ingredient Sales and Value (2012-2017)
8.1.1 Southeast Asia Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2012-2017)
8.1.2 Southeast Asia Active Pharmaceutical Ingredient Revenue and Growth Rate (2012-2017)
8.1.3 Southeast Asia Active Pharmaceutical Ingredient Sales Price Trend (2012-2017)
8.2 Southeast Asia Active Pharmaceutical Ingredient Sales Volume and Market Share by Type
8.3 Southeast Asia Active Pharmaceutical Ingredient Sales Volume and Market Share by Application
9 Australia Active Pharmaceutical Ingredient (Volume, Value and Sales Price)
9.1 Australia Active Pharmaceutical Ingredient Sales and Value (2012-2017)
9.1.1 Australia Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2012-2017)
9.1.2 Australia Active Pharmaceutical Ingredient Revenue and Growth Rate (2012-2017)
9.1.3 Australia Active Pharmaceutical Ingredient Sales Price Trend (2012-2017)
9.2 Australia Active Pharmaceutical Ingredient Sales Volume and Market Share by Type
9.3 Australia Active Pharmaceutical Ingredient Sales Volume and Market Share by Application
10 Asia-Pacific Active Pharmaceutical Ingredient Players/Suppliers Profiles and Sales Data
10.1 Teva
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Active Pharmaceutical Ingredient Product Category, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 Teva Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 Novartis
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Active Pharmaceutical Ingredient Product Category, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 Novartis Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 Pfizer
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Active Pharmaceutical Ingredient Product Category, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 Pfizer Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 Johnson & Johnson
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Active Pharmaceutical Ingredient Product Category, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 Johnson & Johnson Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 Mylan
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Active Pharmaceutical Ingredient Product Category, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 Mylan Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 North China Pharmaceutical Group
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Active Pharmaceutical Ingredient Product Category, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 North China Pharmaceutical Group Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 Dr. Reddy’s Laboratories
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Active Pharmaceutical Ingredient Product Category, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
10.8 Roche
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Active Pharmaceutical Ingredient Product Category, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 Roche Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Main Business/Business Overview
10.9 Aurobindo pharma
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Active Pharmaceutical Ingredient Product Category, Application and Specification
10.9.2.1 Product A
10.9.2.2 Product B
10.9.3 Aurobindo pharma Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Main Business/Business Overview
10.10 Sun Pharmaceutical Industries
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Active Pharmaceutical Ingredient Product Category, Application and Specification
10.10.2.1 Product A
10.10.2.2 Product B
10.10.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
10.10.4 Main Business/Business Overview
10.11 Boehringer Ingelheim GmbH
10.12 Bayer
10.13 BASF
10.14 DSM
10.15 Zhejiang Medicine
10.16 Biocon
10.17 Johnson Matthey
10.18 Hisun Pharmacy
10.19 Cambrex
10.20 Shandong Xinhua Pharmaceutical
10.21 Lonza group
10.22 Huahai Pharmaceutical
10.23 Haerbin Pharmaceutical Group
10.24 Cipla
10.25 Tian Yao
10.26 Lupin
10.27 North East Pharmaceutical
10.28 Albemarle
10.29 Shandong Lukang Pharmaceutical
10.30 Jiangsu?Hengrui Medicine
11 Active Pharmaceutical Ingredient Manufacturing Cost Analysis
11.1 Active Pharmaceutical Ingredient Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredient
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Active Pharmaceutical Ingredient Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Active Pharmaceutical Ingredient Major Manufacturers in 2016
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Market Effect Factors Analysis
14.1 Technology Progress/Risk
14.1.1 Substitutes Threat
14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change
15 Asia-Pacific Active Pharmaceutical Ingredient Market Forecast (2017-2022)
15.1 Asia-Pacific Active Pharmaceutical Ingredient Sales Volume, Revenue and Price Forecast (2017-2022)
15.1.1 Asia-Pacific Active Pharmaceutical Ingredient Sales Volume and Growth Rate Forecast (2017-2022)
15.1.2 Asia-Pacific Active Pharmaceutical Ingredient Revenue and Growth Rate Forecast (2017-2022)
15.1.3 Asia-Pacific Active Pharmaceutical Ingredient Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Active Pharmaceutical Ingredient Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.1 Asia-Pacific Active Pharmaceutical Ingredient Sales Volume and Growth Rate Forecast by Region (2017-2022)
15.2.2 Asia-Pacific Active Pharmaceutical Ingredient Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.3 China Active Pharmaceutical Ingredient Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.4 Japan Active Pharmaceutical Ingredient Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.5 South Korea Active Pharmaceutical Ingredient Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.6 Taiwan Active Pharmaceutical Ingredient Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.7 India Active Pharmaceutical Ingredient Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.8 Southeast Asia Active Pharmaceutical Ingredient Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.9 Australia Active Pharmaceutical Ingredient Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Active Pharmaceutical Ingredient Sales, Revenue and Price Forecast by Type (2017-2022)
15.3.1 Asia-Pacific Active Pharmaceutical Ingredient Sales Forecast by Type (2017-2022)
15.3.2 Asia-Pacific Active Pharmaceutical Ingredient Revenue Forecast by Type (2017-2022)
15.3.3 Asia-Pacific Active Pharmaceutical Ingredient Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Active Pharmaceutical Ingredient Sales Forecast by Application (2017-2022)
16 Research Findings and Conclusion
17 Appendix
17.1 Methodology/Research Approach
17.1.1 Research Programs/Design
17.1.2 Market Size Estimation
17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
17.2.1 Secondary Sources
17.2.2 Primary Sources
17.3 Disclaimer
Figure Product Picture of Active Pharmaceutical Ingredient
Figure Asia-Pacific Active Pharmaceutical Ingredient Sales Volume (K MT) by Type (2012-2022)
Figure Asia-Pacific Active Pharmaceutical Ingredient Sales Volume Market Share by Type (Product Category) in 2016
Figure Synthetic API Product Picture
Figure Biotech API Product Picture
Figure Other Product Picture
Figure Asia-Pacific Active Pharmaceutical Ingredient Sales (K MT) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Active Pharmaceutical Ingredient by Application in 2016
Figure Chemical Examples
Table Key Downstream Customer in Chemical
Figure Deodorant Examples
Table Key Downstream Customer in Deodorant
Figure Dailylife Examples
Table Key Downstream Customer in Dailylife
Figure Asia-Pacific Active Pharmaceutical Ingredient Market Size (Million USD) by Region (2012-2022)
Figure China Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Active Pharmaceutical Ingredient Sales Volume (K MT) and Growth Rate (2012-2022)
Figure Asia-Pacific Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Active Pharmaceutical Ingredient Market Major Players Product Sales Volume (K MT)(2012-2017)
Table Asia-Pacific Active Pharmaceutical Ingredient Sales (K MT) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Active Pharmaceutical Ingredient Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Active Pharmaceutical Ingredient Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Active Pharmaceutical Ingredient Sales Share by Players/Suppliers
Figure Asia-Pacific Active Pharmaceutical Ingredient Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Active Pharmaceutical Ingredient Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Active Pharmaceutical Ingredient Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Active Pharmaceutical Ingredient Revenue Share by Players
Figure 2017 Asia-Pacific Active Pharmaceutical Ingredient Revenue Share by Players
Table Asia-Pacific Active Pharmaceutical Ingredient Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Active Pharmaceutical Ingredient Sales Share by Type (2012-2017)
Figure Sales Market Share of Active Pharmaceutical Ingredient by Type (2012-2017)
Figure Asia-Pacific Active Pharmaceutical Ingredient Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Active Pharmaceutical Ingredient Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Active Pharmaceutical Ingredient Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Active Pharmaceutical Ingredient by Type (2012-2017)
Figure Asia-Pacific Active Pharmaceutical Ingredient Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Active Pharmaceutical Ingredient Sales Volume (K MT) and Market Share by Region (2012-2017)
Table Asia-Pacific Active Pharmaceutical Ingredient Sales Share by Region (2012-2017)
Figure Sales Market Share of Active Pharmaceutical Ingredient by Region (2012-2017)
Figure Asia-Pacific Active Pharmaceutical Ingredient Sales Market Share by Region in 2016
Table Asia-Pacific Active Pharmaceutical Ingredient Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Active Pharmaceutical Ingredient Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Active Pharmaceutical Ingredient by Region (2012-2017)
Figure Asia-Pacific Active Pharmaceutical Ingredient Revenue Market Share by Region in 2016
Table Asia-Pacific Active Pharmaceutical Ingredient Sales Volume (K MT) and Market Share by Application (2012-2017)
Table Asia-Pacific Active Pharmaceutical Ingredient Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Active Pharmaceutical Ingredient Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Active Pharmaceutical Ingredient Sales Market Share by Application (2012-2017)
Figure China Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure China Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Active Pharmaceutical Ingredient Sales Price (USD/MT) Trend (2012-2017)
Table China Active Pharmaceutical Ingredient Sales Volume (K MT) by Type (2012-2017)
Table China Active Pharmaceutical Ingredient Sales Volume Market Share by Type (2012-2017)
Figure China Active Pharmaceutical Ingredient Sales Volume Market Share by Type in 2016
Table China Active Pharmaceutical Ingredient Sales Volume (K MT) by Applications (2012-2017)
Table China Active Pharmaceutical Ingredient Sales Volume Market Share by Application (2012-2017)
Figure China Active Pharmaceutical Ingredient Sales Volume Market Share by Application in 2016
Figure Japan Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure Japan Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Active Pharmaceutical Ingredient Sales Price (USD/MT) Trend (2012-2017)
Table Japan Active Pharmaceutical Ingredient Sales Volume (K MT) by Type (2012-2017)
Table Japan Active Pharmaceutical Ingredient Sales Volume Market Share by Type (2012-2017)
Figure Japan Active Pharmaceutical Ingredient Sales Volume Market Share by Type in 2016
Table Japan Active Pharmaceutical Ingredient Sales Volume (K MT) by Applications (2012-2017)
Table Japan Active Pharmaceutical Ingredient Sales Volume Market Share by Application (2012-2017)
Figure Japan Active Pharmaceutical Ingredient Sales Volume Market Share by Application in 2016
Figure South Korea Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure South Korea Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Active Pharmaceutical Ingredient Sales Price (USD/MT) Trend (2012-2017)
Table South Korea Active Pharmaceutical Ingredient Sales Volume (K MT) by Type (2012-2017)
Table South Korea Active Pharmaceutical Ingredient Sales Volume Market Share by Type (2012-2017)
Figure South Korea Active Pharmaceutical Ingredient Sales Volume Market Share by Type in 2016
Table South Korea Active Pharmaceutical Ingredient Sales Volume (K MT) by Applications (2012-2017)
Table South Korea Active Pharmaceutical Ingredient Sales Volume Market Share by Application (2012-2017)
Figure South Korea Active Pharmaceutical Ingredient Sales Volume Market Share by Application in 2016
Figure Taiwan Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure Taiwan Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Active Pharmaceutical Ingredient Sales Price (USD/MT) Trend (2012-2017)
Table Taiwan Active Pharmaceutical Ingredient Sales Volume (K MT) by Type (2012-2017)
Table Taiwan Active Pharmaceutical Ingredient Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Active Pharmaceutical Ingredient Sales Volume Market Share by Type in 2016
Table Taiwan Active Pharmaceutical Ingredient Sales Volume (K MT) by Applications (2012-2017)
Table Taiwan Active Pharmaceutical Ingredient Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Active Pharmaceutical Ingredient Sales Volume Market Share by Application in 2016
Figure India Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure India Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Active Pharmaceutical Ingredient Sales Price (USD/MT) Trend (2012-2017)
Table India Active Pharmaceutical Ingredient Sales Volume (K MT) by Type (2012-2017)
Table India Active Pharmaceutical Ingredient Sales Volume Market Share by Type (2012-2017)
Figure India Active Pharmaceutical Ingredient Sales Volume Market Share by Type in 2016
Table India Active Pharmaceutical Ingredient Sales Volume (K MT) by Application (2012-2017)
Table India Active Pharmaceutical Ingredient Sales Volume Market Share by Application (2012-2017)
Figure India Active Pharmaceutical Ingredient Sales Volume Market Share by Application in 2016
Figure Southeast Asia Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure Southeast Asia Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Active Pharmaceutical Ingredient Sales Price (USD/MT) Trend (2012-2017)
Table Southeast Asia Active Pharmaceutical Ingredient Sales Volume (K MT) by Type (2012-2017)
Table Southeast Asia Active Pharmaceutical Ingredient Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Active Pharmaceutical Ingredient Sales Volume Market Share by Type in 2016
Table Southeast Asia Active Pharmaceutical Ingredient Sales Volume (K MT) by Applications (2012-2017)
Table Southeast Asia Active Pharmaceutical Ingredient Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Active Pharmaceutical Ingredient Sales Volume Market Share by Application in 2016
Figure Australia Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure Australia Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Active Pharmaceutical Ingredient Sales Price (USD/MT) Trend (2012-2017)
Table Australia Active Pharmaceutical Ingredient Sales Volume (K MT) by Type (2012-2017)
Table Australia Active Pharmaceutical Ingredient Sales Volume Market Share by Type (2012-2017)
Figure Australia Active Pharmaceutical Ingredient Sales Volume Market Share by Type in 2016
Table Australia Active Pharmaceutical Ingredient Sales Volume (K MT) by Applications (2012-2017)
Table Australia Active Pharmaceutical Ingredient Sales Volume Market Share by Application (2012-2017)
Figure Australia Active Pharmaceutical Ingredient Sales Volume Market Share by Application in 2016
Table Teva Active Pharmaceutical Ingredient Basic Information List
Table Teva Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Teva Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure Teva Active Pharmaceutical Ingredient Sales Market Share in Asia-Pacific (2012-2017)
Figure Teva Active Pharmaceutical Ingredient Revenue Market Share in Asia-Pacific (2012-2017)
Table Novartis Active Pharmaceutical Ingredient Basic Information List
Table Novartis Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novartis Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure Novartis Active Pharmaceutical Ingredient Sales Market Share in Asia-Pacific (2012-2017)
Figure Novartis Active Pharmaceutical Ingredient Revenue Market Share in Asia-Pacific (2012-2017)
Table Pfizer Active Pharmaceutical Ingredient Basic Information List
Table Pfizer Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure Pfizer Active Pharmaceutical Ingredient Sales Market Share in Asia-Pacific (2012-2017)
Figure Pfizer Active Pharmaceutical Ingredient Revenue Market Share in Asia-Pacific (2012-2017)
Table Johnson & Johnson Active Pharmaceutical Ingredient Basic Information List
Table Johnson & Johnson Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Johnson & Johnson Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure Johnson & Johnson Active Pharmaceutical Ingredient Sales Market Share in Asia-Pacific (2012-2017)
Figure Johnson & Johnson Active Pharmaceutical Ingredient Revenue Market Share in Asia-Pacific (2012-2017)
Table Mylan Active Pharmaceutical Ingredient Basic Information List
Table Mylan Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Mylan Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure Mylan Active Pharmaceutical Ingredient Sales Market Share in Asia-Pacific (2012-2017)
Figure Mylan Active Pharmaceutical Ingredient Revenue Market Share in Asia-Pacific (2012-2017)
Table North China Pharmaceutical Group Active Pharmaceutical Ingredient Basic Information List
Table North China Pharmaceutical Group Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure North China Pharmaceutical Group Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure North China Pharmaceutical Group Active Pharmaceutical Ingredient Sales Market Share in Asia-Pacific (2012-2017)
Figure North China Pharmaceutical Group Active Pharmaceutical Ingredient Revenue Market Share in Asia-Pacific (2012-2017)
Table Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Basic Information List
Table Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Sales Market Share in Asia-Pacific (2012-2017)
Figure Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Revenue Market Share in Asia-Pacific (2012-2017)
Table Roche Active Pharmaceutical Ingredient Basic Information List
Table Roche Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Roche Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure Roche Active Pharmaceutical Ingredient Sales Market Share in Asia-Pacific (2012-2017)
Figure Roche Active Pharmaceutical Ingredient Revenue Market Share in Asia-Pacific (2012-2017)
Table Aurobindo pharma Active Pharmaceutical Ingredient Basic Information List
Table Aurobindo pharma Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Aurobindo pharma Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure Aurobindo pharma Active Pharmaceutical Ingredient Sales Market Share in Asia-Pacific (2012-2017)
Figure Aurobindo pharma Active Pharmaceutical Ingredient Revenue Market Share in Asia-Pacific (2012-2017)
Table Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Basic Information List
Table Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Sales Market Share in Asia-Pacific (2012-2017)
Figure Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Revenue Market Share in Asia-Pacific (2012-2017)
Table Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Basic Information List
Table Bayer Active Pharmaceutical Ingredient Basic Information List
Table BASF Active Pharmaceutical Ingredient Basic Information List
Table DSM Active Pharmaceutical Ingredient Basic Information List
Table Zhejiang Medicine Active Pharmaceutical Ingredient Basic Information List
Table Biocon Active Pharmaceutical Ingredient Basic Information List
Table Johnson Matthey Active Pharmaceutical Ingredient Basic Information List
Table Hisun Pharmacy Active Pharmaceutical Ingredient Basic Information List
Table Cambrex Active Pharmaceutical Ingredient Basic Information List
Table Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Basic Information List
Table Lonza group Active Pharmaceutical Ingredient Basic Information List
Table Huahai Pharmaceutical Active Pharmaceutical Ingredient Basic Information List
Table Haerbin Pharmaceutical Group Active Pharmaceutical Ingredient Basic Information List
Table Cipla Active Pharmaceutical Ingredient Basic Information List
Table Tian Yao Active Pharmaceutical Ingredient Basic Information List
Table Lupin Active Pharmaceutical Ingredient Basic Information List
Table North East Pharmaceutical Active Pharmaceutical Ingredient Basic Information List
Table Albemarle Active Pharmaceutical Ingredient Basic Information List
Table Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredient Basic Information List
Table Jiangsu?Hengrui Medicine Active Pharmaceutical Ingredient Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/MT) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Active Pharmaceutical Ingredient
Figure Manufacturing Process Analysis of Active Pharmaceutical Ingredient
Figure Active Pharmaceutical Ingredient Industrial Chain Analysis
Table Raw Materials Sources of Active Pharmaceutical Ingredient Major Manufacturers in 2016
Table Major Buyers of Active Pharmaceutical Ingredient
Table Distributors/Traders List
Figure Asia-Pacific Active Pharmaceutical Ingredient Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Active Pharmaceutical Ingredient Price (USD/MT) and Trend Forecast (2017-2022)
Table Asia-Pacific Active Pharmaceutical Ingredient Sales Volume (K MT) Forecast by Region (2017-2022)
Figure Asia-Pacific Active Pharmaceutical Ingredient Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Active Pharmaceutical Ingredient Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Active Pharmaceutical Ingredient Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Active Pharmaceutical Ingredient Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Active Pharmaceutical Ingredient Revenue Market Share Forecast by Region in 2022
Figure China Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure China Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure Japan Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure South Korea Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure Taiwan Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure India Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure Australia Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Active Pharmaceutical Ingredient Sales (K MT) Forecast by Type (2017-2022)
Figure Asia-Pacific Active Pharmaceutical Ingredient Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Active Pharmaceutical Ingredient Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Active Pharmaceutical Ingredient Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Active Pharmaceutical Ingredient Price (USD/MT) Forecast by Type (2017-2022)
Table Asia-Pacific Active Pharmaceutical Ingredient Sales (K MT) Forecast by Application (2017-2022)
Figure Asia-Pacific Active Pharmaceutical Ingredient Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
